BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 28181779)

  • 1. Elevated brain derived neurotrophic factor levels in plasma reflect in vivo functional viability of infused mesenchymal stem cells for stroke in rats.
    Nakamura H; Sasaki Y; Sasaki M; Kataoka-Sasaki Y; Oka S; Nakazaki M; Namioka T; Namioka A; Onodera R; Suzuki J; Nagahama H; Mikami T; Wanibuchi M; Kocsis JD; Honmou O
    J Neurosurg Sci; 2019 Feb; 63(1):42-49. PubMed ID: 28181779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenously Delivered Allogeneic Mesenchymal Stem Cells Bidirectionally Regulate Inflammation and Induce Neurotrophic Effects in Distal Middle Cerebral Artery Occlusion Rats Within the First 7 Days After Stroke.
    Li X; Huang M; Zhao R; Zhao C; Liu Y; Zou H; Chen L; Guan Y; Zhang YA
    Cell Physiol Biochem; 2018; 46(5):1951-1970. PubMed ID: 29719282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesenchymal stem cell transplantation attenuates brain injury after neonatal stroke.
    van Velthoven CT; Sheldon RA; Kavelaars A; Derugin N; Vexler ZS; Willemen HL; Maas M; Heijnen CJ; Ferriero DM
    Stroke; 2013 May; 44(5):1426-32. PubMed ID: 23539530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bilateral cortical hyperactivity detected by fMRI associates with improved motor function following intravenous infusion of mesenchymal stem cells in a rat stroke model.
    Suzuki J; Sasaki M; Harada K; Bando M; Kataoka Y; Onodera R; Mikami T; Wanibuchi M; Mikuni N; Kocsis JD; Honmou O
    Brain Res; 2013 Feb; 1497():15-22. PubMed ID: 23274536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. I.V. infusion of brain-derived neurotrophic factor gene-modified human mesenchymal stem cells protects against injury in a cerebral ischemia model in adult rat.
    Nomura T; Honmou O; Harada K; Houkin K; Hamada H; Kocsis JD
    Neuroscience; 2005; 136(1):161-9. PubMed ID: 16229956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergic Effects of Rehabilitation and Intravenous Infusion of Mesenchymal Stem Cells After Stroke in Rats.
    Sasaki Y; Sasaki M; Kataoka-Sasaki Y; Nakazaki M; Nagahama H; Suzuki J; Tateyama D; Oka S; Namioka T; Namioka A; Onodera R; Mikami T; Wanibuchi M; Kakizawa M; Ishiai S; Kocsis JD; Honmou O
    Phys Ther; 2016 Nov; 96(11):1791-1798. PubMed ID: 27174259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesenchymal stem cells expressing brain-derived neurotrophic factor enhance endogenous neurogenesis in an ischemic stroke model.
    Jeong CH; Kim SM; Lim JY; Ryu CH; Jun JA; Jeun SS
    Biomed Res Int; 2014; 2014():129145. PubMed ID: 24672780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparsion between Intravenous Delivered Human Fetal Bone Marrow Mesenchymal Stromal Cells and Mononuclear Cells in the Treatment of Rat Cerebral Infarct.
    Huang AH; Zhang PP; Zhang B; Ma BQ; Guan YQ; Zhou YD
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2016 Oct; 38(5):497-506. PubMed ID: 27825404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenovirus vector-mediated ex vivo gene transfer of brain-derived neurotrophic factor (BDNF) tohuman umbilical cord blood-derived mesenchymal stem cells (UCB-MSCs) promotescrush-injured rat sciatic nerve regeneration.
    Hei WH; Almansoori AA; Sung MA; Ju KW; Seo N; Lee SH; Kim BJ; Kim SM; Jahng JW; He H; Lee JH
    Neurosci Lett; 2017 Mar; 643():111-120. PubMed ID: 28215880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotective effect of human placenta-derived cell treatment of stroke in rats.
    Chen J; Shehadah A; Pal A; Zacharek A; Cui X; Cui Y; Roberts C; Lu M; Zeitlin A; Hariri R; Chopp M
    Cell Transplant; 2013; 22(5):871-9. PubMed ID: 22469567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BDNF gene-modified mesenchymal stem cells promote functional recovery and reduce infarct size in the rat middle cerebral artery occlusion model.
    Kurozumi K; Nakamura K; Tamiya T; Kawano Y; Kobune M; Hirai S; Uchida H; Sasaki K; Ito Y; Kato K; Honmou O; Houkin K; Date I; Hamada H
    Mol Ther; 2004 Feb; 9(2):189-97. PubMed ID: 14759803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Mesenchymal Stem Cell Treatment on the Expression of Matrix Metalloproteinases and Angiogenesis during Ischemic Stroke Recovery.
    Nam HS; Kwon I; Lee BH; Kim H; Kim J; An S; Lee OH; Lee PH; Kim HO; Namgoong H; Kim YD; Heo JH
    PLoS One; 2015; 10(12):e0144218. PubMed ID: 26637168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous infusion of mesenchymal stem cells inhibits intracranial hemorrhage after recombinant tissue plasminogen activator therapy for transient middle cerebral artery occlusion in rats.
    Nakazaki M; Sasaki M; Kataoka-Sasaki Y; Oka S; Namioka T; Namioka A; Onodera R; Suzuki J; Sasaki Y; Nagahama H; Mikami T; Wanibuchi M; Kocsis JD; Honmou O
    J Neurosurg; 2017 Oct; 127(4):917-926. PubMed ID: 28059661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroprotection by PlGF gene-modified human mesenchymal stem cells after cerebral ischaemia.
    Liu H; Honmou O; Harada K; Nakamura K; Houkin K; Hamada H; Kocsis JD
    Brain; 2006 Oct; 129(Pt 10):2734-45. PubMed ID: 16901914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous Infusion of Mesenchymal Stem Cells Enhances Therapeutic Efficacy of Reperfusion Therapy in Cerebral Ischemia.
    Kiyose R; Sasaki M; Kataoka-Sasaki Y; Nakazaki M; Nagahama H; Magota H; Oka S; Ukai R; Takemura M; Yokoyama T; Kocsis JD; Honmou O
    World Neurosurg; 2021 May; 149():e160-e169. PubMed ID: 33618048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapeutic efficacy of lentiviral vector mediated BDNF gene-modified MSCs in cerebral infarction].
    Huang D; Zhang Z; Chen B; Wu X; Wang N; Zhang Y
    Sheng Wu Gong Cheng Xue Bao; 2008 Jul; 24(7):1174-9. PubMed ID: 18837391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison between the effect of human Wharton's jelly-derived mesenchymal stem cells and levetiracetam on brain infarcts in rats.
    Abd El Motteleb DM; Hussein S; Hasan MM; Mosaad H
    J Cell Biochem; 2018 Dec; 119(12):9790-9800. PubMed ID: 30171723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroprotective Effects of Brain-Derived Neurotrophic Factor and Noggin-Modified Bone Mesenchymal Stem Cells in Focal Cerebral Ischemia in Rats.
    Lu H; Liu X; Zhang N; Zhu X; Liang H; Sun L; Cheng Y
    J Stroke Cerebrovasc Dis; 2016 Feb; 25(2):410-8. PubMed ID: 26654668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preservation of interhemispheric cortical connections through corpus callosum following intravenous infusion of mesenchymal stem cells in a rat model of cerebral infarction.
    Nagahama H; Nakazaki M; Sasaki M; Kataoka-Sasaki Y; Namioka T; Namioka A; Oka S; Onodera R; Suzuki J; Sasaki Y; Kocsis JD; Honmou O
    Brain Res; 2018 Sep; 1695():37-44. PubMed ID: 29802840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transplantation of human mesenchymal stem cells promotes functional improvement and increased expression of neurotrophic factors in a rat focal cerebral ischemia model.
    Wakabayashi K; Nagai A; Sheikh AM; Shiota Y; Narantuya D; Watanabe T; Masuda J; Kobayashi S; Kim SU; Yamaguchi S
    J Neurosci Res; 2010 Apr; 88(5):1017-25. PubMed ID: 19885863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.